COVID-19 Vaccine Failure in Patients With Blood Cancers COVID-19 Vaccine Failure in Patients With Blood Cancers

Almost half of patients with hematologic malignancies failed to produce antibodies against SARS-CoV-2 after full vaccination and thus remained at risk for COVID-19 infection.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news